NNC0537-1482
/ Novo Nordisk
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
December 06, 2025
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Biomarker • Enrollment open • Cardiovascular • Congestive Heart Failure • Heart Failure
October 21, 2025
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
(clinicaltrials.gov)
- P1 | N=36 | Not yet recruiting | Sponsor: Novo Nordisk A/S
Biomarker • New P1 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
June 27, 2025
A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin
(clinicaltrials.gov)
- P1 | N=31 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed | N=56 ➔ 31
Enrollment change • Trial completion • Cardiovascular • Congestive Heart Failure • Heart Failure
October 18, 2024
A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin
(clinicaltrials.gov)
- P1 | N=56 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Congestive Heart Failure • Heart Failure
1 to 4
Of
4
Go to page
1